Clinical Research

Proven efficacy

• Over 20 human clinical studies have been conducted with dairy peptides over the past 10 years to demonstrate their blood pressure lowering effect.

• A recent human clinical study using TensGuard™ has shown a statistically significant reduction of systolic* and diastolic blood pressure by 3.8 and 2.3 mmHg, respectively, in people with mild hypertension.

• No adverse effects have been reported in any of the human trials conducted over the past ten years. There was no detectable reduction in blood pressure in individuals with normal blood pressure.

* There are two measures for blood pressure, the first being systolic blood pressure; this is the pressure the blood exerts on the arteries when the heart beats. The second measure is diastolic pressure; this is the pressure the blood exerts on the arteries when the heart relaxes between beats.